Biotech Act Commission estimates the cost of Biotech Act protections at €210 million per year A Commission Staff Working Document supporting the Biotech Act I presented in December shows that the estimated cost of an extension to supplementary protection certificates could exceed €210 million per year
Biotech Act Europe pushes to regain ground on competitors with new Biotech Act With the publication of the Biotech Act, the EU sets out how it intends to boost the sector’s competitive position in the face of China’s rapid rise
